MX9603596A - Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas. - Google Patents
Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.Info
- Publication number
- MX9603596A MX9603596A MX9603596A MX9603596A MX9603596A MX 9603596 A MX9603596 A MX 9603596A MX 9603596 A MX9603596 A MX 9603596A MX 9603596 A MX9603596 A MX 9603596A MX 9603596 A MX9603596 A MX 9603596A
- Authority
- MX
- Mexico
- Prior art keywords
- perfluoropolyether compounds
- viral infections
- fomblin
- perfluoropolyether
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyethers (AREA)
Abstract
Uso de perfluoropoliéteres con terminales no reactivos o composiciones de los mismos par ala prevencion y/o el tratamiento de infecciones virales topicas, en particular de Herpes Simplex I y II y de Herpes Zoster.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US266595P | 1995-08-22 | 1995-08-22 | |
US002665 | 1995-08-22 | ||
MIMI96A001070 | 1996-05-28 | ||
MIMI96/A001070 | 1996-05-28 | ||
IT96MI001070 IT1282748B1 (it) | 1996-05-28 | 1996-05-28 | Prevenzione e trattamento delle infezioni virali topiche con perfluoropolieteri o loro composizioni. |
Publications (2)
Publication Number | Publication Date |
---|---|
MXPA96003596A MXPA96003596A (es) | 1997-06-01 |
MX9603596A true MX9603596A (es) | 1997-06-28 |
Family
ID=26331394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9603596A MX9603596A (es) | 1995-08-22 | 1996-08-21 | Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5719194A (es) |
EP (1) | EP0759301B1 (es) |
JP (1) | JPH09136838A (es) |
KR (1) | KR100420260B1 (es) |
AT (1) | ATE201591T1 (es) |
AU (1) | AU706952B2 (es) |
CA (1) | CA2183804A1 (es) |
DE (1) | DE69613058T2 (es) |
MX (1) | MX9603596A (es) |
TW (1) | TW415844B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN030794A0 (en) | 1994-12-22 | 1995-01-27 | Aruba International Pty Ltd | Discontinuous plasma or serum delipidation |
US7407663B2 (en) * | 2000-06-29 | 2008-08-05 | Lipid Sciences, Inc. | Modified immunodeficiency virus particles |
US20090017069A1 (en) * | 2000-06-29 | 2009-01-15 | Lipid Sciences, Inc. | SARS Vaccine Compositions and Methods of Making and Using Them |
AUPQ846900A0 (en) * | 2000-06-29 | 2000-07-27 | Aruba International Pty Ltd | A vaccine |
US7407662B2 (en) * | 2000-06-29 | 2008-08-05 | Lipid Sciences, Inc. | Modified viral particles with immunogenic properties and reduced lipid content |
US7439052B2 (en) * | 2000-06-29 | 2008-10-21 | Lipid Sciences | Method of making modified immunodeficiency virus particles |
WO2003000373A1 (en) * | 2001-06-25 | 2003-01-03 | Lipid Sciences, Inc. | Systems and methods using a solvent for the removal of lipids from fluids |
EP1409108A4 (en) * | 2001-06-25 | 2007-11-14 | Lipid Sciences Inc | HOLLOW FIBER CONTACTOR SYSTEMS FOR THE REMOVAL OF LIPIDS FROM LIQUIDS |
US20060060520A1 (en) * | 2001-06-25 | 2006-03-23 | Bomberger David C | Systems and methods using a solvent for the removal of lipids from fluids |
US6991727B2 (en) | 2001-06-25 | 2006-01-31 | Lipid Sciences, Inc. | Hollow fiber contactor systems for removal of lipids from fluids |
US7033500B2 (en) * | 2001-06-25 | 2006-04-25 | Lipid Sciences, Inc. | Systems and methods using multiple solvents for the removal of lipids from fluids |
AU2003268190B2 (en) * | 2002-08-26 | 2008-04-03 | Eli Lilly And Company | Treating Alzheimers using delipidated protein particles |
ES2715496T3 (es) * | 2003-07-03 | 2019-06-04 | Hdl Therapeutics Inc | Métodos y aparatos para crear derivados de partículas de HDL con un contenido reducido de lípidos |
US7393826B2 (en) | 2003-07-03 | 2008-07-01 | Lipid Sciences, Inc. | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
US6960803B2 (en) * | 2003-10-23 | 2005-11-01 | Silicon Storage Technology, Inc. | Landing pad for use as a contact to a conductive spacer |
US8946134B2 (en) * | 2009-02-27 | 2015-02-03 | Ntn Corporation | Grease composition, grease-packed bearing, universal joint for propeller shaft, lubricating oil composition, and oil-impregnated sintered bearing |
JP6284956B2 (ja) | 2013-02-19 | 2018-02-28 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッド | 瘢痕組織の外観及び形成を改善するための方法並びに組成物 |
AU2018372198A1 (en) | 2017-11-22 | 2020-06-11 | Hdl Therapeutics, Inc. | Systems and methods for priming fluid circuits of a plasma processing system |
EP3731814A4 (en) | 2017-12-28 | 2021-09-29 | HDL Therapeutics, Inc. | PROCESSES FOR THE STORAGE AND ADMINISTRATION OF HIGH DENSITY PRE-BETA LIPOPROTEINS EXTRACTED FROM HUMAN PLASMA |
RU2697886C1 (ru) * | 2018-08-06 | 2019-08-21 | Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) | Противовирусная композиция |
RU2697887C1 (ru) * | 2018-08-06 | 2019-08-21 | Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) | Средство, обладающее противовирусным действием в отношении вирусов клещевого энцефалита и герпеса простого I типа |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3897502A (en) * | 1971-10-22 | 1975-07-29 | Airco Inc | Process for making fluorinated ethers |
IT1183530B (it) * | 1985-03-29 | 1987-10-22 | Monteluos S P A | Composizioni per cosmesi comprendente perfluoropolieteri |
IL82308A (en) * | 1986-06-26 | 1990-11-29 | Ausimont Spa | Microemulsions containing perfluoropolyethers |
IT1229222B (it) * | 1989-03-31 | 1991-07-26 | Ausimont Srl | Emulsioni stabili di perfluoropolieteri |
IT1244032B (it) * | 1990-12-18 | 1994-06-28 | Ausimont Spa | Emulsioni stabili di perfluoropolieteri e sostanze grasse e processo per la loro preparazione |
-
1996
- 1996-06-07 US US08/663,022 patent/US5719194A/en not_active Expired - Lifetime
- 1996-07-11 DE DE69613058T patent/DE69613058T2/de not_active Expired - Fee Related
- 1996-07-11 EP EP96111163A patent/EP0759301B1/en not_active Expired - Lifetime
- 1996-07-11 AT AT96111163T patent/ATE201591T1/de not_active IP Right Cessation
- 1996-08-01 JP JP8203755A patent/JPH09136838A/ja active Pending
- 1996-08-21 KR KR1019960034683A patent/KR100420260B1/ko not_active IP Right Cessation
- 1996-08-21 CA CA002183804A patent/CA2183804A1/en not_active Abandoned
- 1996-08-21 MX MX9603596A patent/MX9603596A/es unknown
- 1996-08-21 AU AU62189/96A patent/AU706952B2/en not_active Ceased
- 1996-09-20 TW TW085111509A patent/TW415844B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE201591T1 (de) | 2001-06-15 |
KR100420260B1 (ko) | 2004-06-04 |
JPH09136838A (ja) | 1997-05-27 |
EP0759301A3 (en) | 1997-10-01 |
AU6218996A (en) | 1997-03-13 |
TW415844B (en) | 2000-12-21 |
DE69613058T2 (de) | 2002-03-07 |
EP0759301A2 (en) | 1997-02-26 |
CA2183804A1 (en) | 1997-02-23 |
DE69613058D1 (de) | 2001-07-05 |
AU706952B2 (en) | 1999-07-01 |
US5719194A (en) | 1998-02-17 |
KR970009797A (ko) | 1997-03-27 |
EP0759301B1 (en) | 2001-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9603596A (es) | Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas. | |
BG101118A (en) | Therapeutical compounds | |
EP1419803A3 (en) | Pharmaceutical composition for topical administration comprising an antiviral substance and a glucocorticoid | |
CA2274074A1 (en) | Novel compounds with analgesic effect | |
CA2254079A1 (en) | Androstene derivatives | |
CA2289717A1 (en) | Novel therapy for constipation | |
IL122733A0 (en) | Pharmaceutical compositions for use in the treatment of allergic asthma | |
HK1030157A1 (en) | Use of consensus interferon and compositions comprising consensus interferon. | |
AU1937395A (en) | Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic | |
PL323490A1 (en) | Tetralinic compounds exibiting acitity against multgiple-drug refractoriness | |
GR3027749T3 (en) | Cosmetic or pharmaceutical composition for topical application active against free radicals. | |
WO1997004788A3 (en) | Use of calendula glycosides for the treatment of psoriasis | |
UA35611C2 (uk) | Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри | |
ES2009140A6 (es) | Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen. | |
RS49599B (sr) | Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija | |
CA2275167A1 (en) | The topical use of kappa opioid agonists to treat ocular pain | |
TR199900661T2 (xx) | Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m� | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
AU4678893A (en) | Compositions and methods for topical treatment of skin lesions | |
AU3435189A (en) | Topically applied gold organic complex | |
CA2113080A1 (en) | Topical composition containing penciclovir | |
AU3992897A (en) | Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders | |
CA2149766A1 (en) | Rectal flunisolide compositions for treating inflammatory intestinal disorders | |
EP1061802A4 (en) | TOPICAL CARBAMAZEPINE FORMULATIONS AND THEIR USE | |
IT1264428B1 (it) | Composizioni farmaceutiche per il trattamento della psoriasi |